 Farbenindustrie at Hoechst during the Second World War.The first study of it in humans was published in 1946, and it was introduced in clinical medicine shortly after.It was not in clinical use in the United States when the Controlled Substances Act 1970 was promulgated and was assigned to Schedule I with an ACSCN of 9628.